Brand Name: Aptima HPV Assay Product Name: Aptima HPV Assay Model/Catalog Number: 303585 Produ...

FDA Device Recall #Z-1586-2026 — Class II — February 18, 2026

Recall Summary

Recall Number Z-1586-2026
Classification Class II — Moderate risk
Date Initiated February 18, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hologic, Inc.
Location San Diego, CA
Product Type Devices
Quantity 306

Product Description

Brand Name: Aptima HPV Assay Product Name: Aptima HPV Assay Model/Catalog Number: 303585 Product Description: Aptima HPV assay Component: No

Reason for Recall

Due to product exhibiting potential to generate either invalid or false negative results.

Distribution Pattern

U.S. Nationwide distribution in the states of CA, FL. IA, IL, MO, NC, NM, PR, and TN.

Lot / Code Information

Lot Code: The Aptima HPV Assay Kit Part Number 303585, Master Lot 929785 contains one Refrigerated Box (PN 302883) and one Room Temperature Box (PN 302885). The following are the UDI number for each box: UDI Number for PN 302883: 15420045500051 UDI Number for PN 302885: 15420045500068

Other Recalls from Hologic, Inc.

Recall # Classification Product Date
Z-1095-2025 Class II The Rapid fFN Specimen Collection Tube (PN: 715... Jan 8, 2025
Z-0907-2025 Class II Panther Fusion GBS Assay REF PRD-04484 Kit cont... Dec 13, 2024
Z-0694-2025 Class II Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, RE... Nov 8, 2024
Z-0782-2024 Class II PANTHER FUSION System REF 9121010000 The P... Dec 15, 2023
Z-1371-2024 Class II Aptima CMV Quant Assay, Reference numbers: AW-2... Sep 14, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.